Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 74

1.

Genetic biomarkers for hepatocellular cancer risk in a caucasian population.

De Mattia E, Cecchin E, Polesel J, Bignucolo A, Roncato R, Lupo F, Crovatto M, Buonadonna A, Tiribelli C, Toffoli G.

World J Gastroenterol. 2017 Sep 28;23(36):6674-6684. doi: 10.3748/wjg.v23.i36.6674.

2.

UGT1A polymorphisms as genetic biomarkers for hepatocellular carcinoma risk in Caucasian population.

De Mattia E, Cecchin E, Polesel J, Lupo F, Tiribelli C, Crovatto M, Buonadonna A, Toffoli G.

Liver Int. 2017 Sep;37(9):1345-1353. doi: 10.1111/liv.13411. Epub 2017 Apr 6.

PMID:
28294511
3.

Impact of immunogenetic IL28B polymorphism on natural outcome of HCV infection.

De Re V, Gragnani L, Fognani E, Piluso A, Izzo F, Mangia A, Crovatto M, Gava G, Casarin P, Sansonno D, Racanelli V, De Vita S, Pioltelli P, Caggiari L, De Zorzi M, Berretta M, Gini A, Zucchetto A, Buonaguro FM, De Paoli P, Zignego AL.

Biomed Res Int. 2014;2014:710642. doi: 10.1155/2014/710642. Epub 2014 Feb 26.

4.

A new human leukocyte antigen class I allele: HLA-A*02:374.

De Zorzi M, Caggiari L, Crovatto M, Talamini R, Garziera M, De Re V.

Tissue Antigens. 2013 Jan;81(1):48-9. doi: 10.1111/tan.12039.

PMID:
23216289
5.

Evaluation of a "home-made" method to determine viral genotype and characterize mutations conferring drug resistance in chronic hepatitis B patients.

Pagani E, Pasquetto V, Cemin C, Rossi P, Crovatto M, Gava G, Felder M, Huemer HP, Larcher C.

Infez Med. 2012 Jun;20(2):88-92.

6.

Heterozygous variant at nucleotide position 875+11A>T in exon 6A cystic fibrosis transmembrane conductance regulator gene induces 852del22 mutation false-positivity by line probe assay.

Miolo G, Crovatto M, Manno M, Pivetta B, Tessitori G, Picci L.

Fertil Steril. 2011 Mar 1;95(3):1121.e1-4. doi: 10.1016/j.fertnstert.2010.09.042. Epub 2010 Nov 10.

PMID:
21067729
7.

HLA DR-DQ combination associated with the increased risk of developing human HCV positive non-Hodgkin's lymphoma is related to the type II mixed cryoglobulinemia.

De Re V, Caggiari L, Monti G, Libra M, Spina M, Dolcetti R, De Zorzi M, Racanelli V, Crovatto M, Toffoli G.

Tissue Antigens. 2010 Feb;75(2):127-35. doi: 10.1111/j.1399-0039.2009.01414.x. Epub 2009 Dec 9.

PMID:
20002609
8.

Nutrients intake and the risk of hepatocellular carcinoma in Italy.

Polesel J, Talamini R, Montella M, Maso LD, Crovatto M, Parpinel M, Izzo F, Tommasi LG, Serraino D, La Vecchia C, Franceschi S.

Eur J Cancer. 2007 Nov;43(16):2381-7. Epub 2007 Aug 23.

PMID:
17719221
9.

Coffee and tea consumption and risk of hepatocellular carcinoma in Italy.

Montella M, Polesel J, La Vecchia C, Dal Maso L, Crispo A, Crovatto M, Casarin P, Izzo F, Tommasi LG, Talamini R, Franceschi S.

Int J Cancer. 2007 Apr 1;120(7):1555-9.

10.

Food groups and risk of hepatocellular carcinoma: A multicenter case-control study in Italy.

Talamini R, Polesel J, Montella M, Dal Maso L, Crispo A, Tommasi LG, Izzo F, Crovatto M, La Vecchia C, Franceschi S.

Int J Cancer. 2006 Dec 15;119(12):2916-21.

11.

Hepatitis viruses, alcohol, and tobacco in the etiology of hepatocellular carcinoma in Italy.

Franceschi S, Montella M, Polesel J, La Vecchia C, Crispo A, Dal Maso L, Casarin P, Izzo F, Tommasi LG, Chemin I, Trépo C, Crovatto M, Talamini R.

Cancer Epidemiol Biomarkers Prev. 2006 Apr;15(4):683-9.

12.

Linoleic acid, vitamin D and other nutrient intakes in the risk of non-Hodgkin lymphoma: an Italian case-control study.

Polesel J, Talamini R, Montella M, Parpinel M, Dal Maso L, Crispo A, Crovatto M, Spina M, La Vecchia C, Franceschi S.

Ann Oncol. 2006 Apr;17(4):713-8.

PMID:
16556850
13.

Food groups and risk of non-Hodgkin lymphoma: a multicenter, case-control study in Italy.

Talamini R, Polesel J, Montella M, Dal Maso L, Crovatto M, Crispo A, Spina M, Canzonieri V, La Vecchia C, Franceschi S.

Int J Cancer. 2006 Jun 1;118(11):2871-6.

14.

False positive reactions for IgA and IgG anti-tissue transglutaminase antibodies in liver cirrhosis are common and method-dependent.

Villalta D, Crovatto M, Stella S, Tonutti E, Tozzoli R, Bizzaro N.

Clin Chim Acta. 2005 Jun;356(1-2):102-9. Epub 2005 Mar 19.

PMID:
15936306
15.

Smoking and non-Hodgkin lymphoma: case-control study in Italy.

Talamini R, Polesel J, Montella M, Maso LD, Crispo A, Spina M, Franceschi S, Crovatto M, La Vecchia C.

Int J Cancer. 2005 Jul 1;115(4):606-10.

16.

Hepatitis C virus-related hepatocellular carcinoma and B-cell lymphoma patients show a different profile of major histocompatibility complex class II alleles.

De Re V, Caggiari L, Talamini R, Crovatto M, De Vita S, Mazzaro C, Cannizzaro R, Dolcetti R, Boiocchi M.

Hum Immunol. 2004 Nov;65(11):1397-404.

PMID:
15556690
17.

Hepatitis B and C viruses and Hodgkin lymphoma: a case-control study from Northern and Southern Italy.

Dal Maso L, Talamini R, Montella M, Crovatto M, Franceschi S.

Haematologica. 2004 Nov;89(11):ELT17. No abstract available.

18.

Non-Hodgkin's lymphoma and hepatitis C virus: a case-control study from northern and southern Italy.

Talamini R, Montella M, Crovatto M, Dal Maso L, Crispo A, Negri E, Spina M, Pinto A, Carbone A, Franceschi S.

Int J Cancer. 2004 Jun 20;110(3):380-5.

19.

Preliminary evidence on the safety of ICSI with testicular spermatozoa in HCV-infected male: a case report.

Manno M, Marchesan E, Crovatto M, Martelli P, Tomei F, Adamo V.

Hum Reprod. 2003 Aug;18(8):1666-8.

PMID:
12871879
20.

Performance assessment of new multiplex probe assay for identification of mycobacteria.

Tortoli E, Nanetti A, Piersimoni C, Cichero P, Farina C, Mucignat G, Scarparo C, Bartolini L, Valentini R, Nista D, Gesu G, Tosi CP, Crovatto M, Brusarosco G.

J Clin Microbiol. 2001 Mar;39(3):1079-84.

21.

Interferon versus steroids in patients with hepatitis C virus-associated cryoglobulinaemic glomerulonephritis.

Mazzaro C, Panarello G, Carniello S, Faelli A, Mazzi G, Crovatto M, Baracetti S, Nascimben F, Zorat F, Pozzato G, Faccini L, Campanacci L.

Dig Liver Dis. 2000 Nov;32(8):708-15.

PMID:
11142582
22.

Hepatitis C virus risk: a hepatitis C virus related syndrome.

Mazzaro C, Panarello G, Tesio F, Santini G, Crovatto M, Mazzi G, Zorat F, Tulissi P, Pussini E, Baracetti S, Campanacci L, Pozzato G.

J Intern Med. 2000 May;247(5):535-45.

23.

Peripheral blood neutrophils from hepatitis C virus-infected patients are replication sites of the virus.

Crovatto M, Pozzato G, Zorat F, Pussini E, Nascimben F, Baracetti S, Grando MG, Mazzaro C, Reitano M, Modolo ML, Martelli P, Spada A, Santini G.

Haematologica. 2000 Apr;85(4):356-61.

24.

Long-term treatment of chronic hepatitis C with ursodeoxycholic acid: influence of HCV genotypes and severity of liver disease.

Lirussi F, Beccarello A, Bortolato L, Morselli-Labate AM, Crovatto M, Ceselli S, Santini G, Crepaldi G.

Liver. 1999 Oct;19(5):381-8.

PMID:
10533795
25.

GBV-C/HGV and HCV infection in mixed cryoglobulinaemia.

Crovatto M, Mazzaro C, Mishiro S, Santini G, Baracetti S, Zorat F, Pozzato G.

Br J Haematol. 1999 Aug;106(2):510-4.

PMID:
10460613
26.

Clinical course and risk factors of hepatitis C virus related liver disease in the general population: report from the Dionysos study.

Bellentani S, Pozzato G, Saccoccio G, Crovatto M, Crocè LS, Mazzoran L, Masutti F, Cristianini G, Tiribelli C.

Gut. 1999 Jun;44(6):874-80.

27.

Cryoglobulinaemic membranoproliferative glomerulonephritis and hepatitis C virus infection.

Mazzaro C, Pozzato G, Zorat F, Panarello G, Silvestri F, Barillari G, Mazzoran L, Baracetti S, Crovatto M, Santini GF, Donadon V, Faccini L, Campanacci L.

Ital J Gastroenterol Hepatol. 1999 Jan-Feb;31(1):45-53.

PMID:
10091102
28.

Hepatitis C virus and immunoglobulin gene rearrangements: an early step in lymphomagenesis?

Santini GF, Crovatto M, Giannini F, Bortolin MT, Mazzaro C, Invernizzi F.

Acta Haematol. 1998 Dec;100(3):117-22.

PMID:
9858787
29.

Systemic manifestations and liver disease in patients with chronic hepatitis C and type II or III mixed cryoglobulinaemia.

Donada C, Crucitti A, Donadon V, Tommasi L, Zanette G, Crovatto M, Santini GF, Chemello L, Alberti A.

J Viral Hepat. 1998 May;5(3):179-85.

PMID:
9658371
30.

Interferon therapy in HCV-positive mixed cryoglobulinaemia: viral and host factors contributing to efficacy of the therapy.

Mazzaro C, Carniello GS, Colle R, Doretto P, Mazzi G, Crovatto M, Santini GF, Tulissi P, Gregoretti M, Mazzoran L, Russo A, Silvestri F, Pozzato G.

Ital J Gastroenterol Hepatol. 1997 Aug;29(4):343-50.

PMID:
9476189
31.

Characterization of overt B-cell lymphomas in patients with hepatitis C virus infection.

De Vita S, Sacco C, Sansonno D, Gloghini A, Dammacco F, Crovatto M, Santini G, Dolcetti R, Boiocchi M, Carbone A, Zagonel V.

Blood. 1997 Jul 15;90(2):776-82.

32.

Detection of genotype 4 hepatitis C virus (HCV) in Italy.

Tagliaferro L, Corbelli M, Crovatto M, Santini GF.

New Microbiol. 1997 Jan;20(1):87-8. No abstract available.

PMID:
9037674
33.

Hepatitis C virus and non-Hodgkin's lymphomas.

Mazzaro C, Zagonel V, Monfardini S, Tulissi P, Pussini E, Fanni M, Sorio R, Bortolus R, Crovatto M, Santini G, Tiribelli C, Sasso F, Masutti R, Pozzato G.

Br J Haematol. 1996 Sep;94(3):544-50.

PMID:
8790157
34.

Regression of monoclonal B-cell expansion in patients affected by mixed cryoglobulinemia responsive to alpha-interferon therapy.

Mazzaro C, Franzin F, Tulissi P, Pussini E, Crovatto M, Carniello GS, Efremov DG, Burrone O, Santini G, Pozzato G.

Cancer. 1996 Jun 15;77(12):2604-13.

PMID:
8640712
35.

HCV genotypes and cryoglobulinemia.

Crovatto M, Ceselli S, Mazzaro C, Modolo ML, Martelli P, Mazzi G, Pozzato G, Giannini F, Barbisin M, Chiarotto B, et al.

Clin Exp Rheumatol. 1995 Nov-Dec;13 Suppl 13:S79-82.

PMID:
8730482
36.

HCV and lymphoproliferative diseases.

Santini GF, Giannini F, Crovatto M, Ceselli S, Mazzaro C, Donada C, Mazzi G, Pozzato G, Sulfaro S, Romanelli M, et al.

Clin Exp Rheumatol. 1995 Nov-Dec;13 Suppl 13:S51-7.

PMID:
8730477
37.

Hepatitis C virus within a malignant lymphoma lesion in the course of type II mixed cryoglobulinemia.

De Vita S, Sansonno D, Dolcetti R, Ferraccioli G, Carbone A, Cornacchiulo V, Santini G, Crovatto M, Gloghini A, Dammacco F, Boiocchi M.

Blood. 1995 Sep 1;86(5):1887-92.

38.

Clinical and virological findings in mixed cryoglobulinaemia.

Mazzaro C, Tulissi P, Moretti M, Mazzoran L, Pussini E, Crovatto M, Santini GF, Pozzato G.

J Intern Med. 1995 Aug;238(2):153-60.

PMID:
7629483
39.

Interferon therapy in chronic hepatitis C virus: evidence of different outcome with respect to different viral strains.

Pozzato G, Moretti M, Crocé LS, Sasso F, Kaneko S, Unoura M, Kobayashi K, Crovatto M, Santini G, Tiribelli C.

J Med Virol. 1995 Apr;45(4):445-50.

PMID:
7666045
40.

Low-grade malignant lymphoma, hepatitis C virus infection, and mixed cryoglobulinemia.

Pozzato G, Mazzaro C, Crovatto M, Modolo ML, Ceselli S, Mazzi G, Sulfaro S, Franzin F, Tulissi P, Moretti M, et al.

Blood. 1994 Nov 1;84(9):3047-53.

41.

Different genotypes of hepatitis C virus are associated with different severity of chronic liver disease.

Pozzato G, Kaneko S, Moretti M, Crocè LS, Franzin F, Unoura M, Bercich L, Tiribelli C, Crovatto M, Santini G, et al.

J Med Virol. 1994 Jul;43(3):291-6.

PMID:
7931191
42.

Long-term effects of alpha-interferon therapy for type II mixed cryoglobulinemia.

Mazzaro C, Pozzato G, Moretti M, Crovatto M, Modolo ML, Mazzi G, Santini G.

Haematologica. 1994 Jul-Aug;79(4):342-9. Erratum in: Haematologica 1994 Sep-Oct;79(5):486.

43.

Lymphocyte subsets in HCV-positive chronic liver disease.

Pozzato G, Moretti M, Crovatto M, Modolo ML, Gennari D, Santini G.

Immunol Today. 1994 Mar;15(3):137-8. No abstract available.

PMID:
8172648
44.

Waldenström macroglobulinemia: a role of HCV infection?

Santini GF, Crovatto M, Modolo ML, Martelli P, Silvia C, Mazzi G, Franzin F, Moretti M, Tulissi P, Pozzato G.

Blood. 1993 Nov 1;82(9):2932. No abstract available.

45.

Infections in an Alpine environment: antibodies to hantaviruses, leptospira, rickettsiae, and Borrelia burgdorferi in defined Italian populations.

Nuti M, Amaddeo D, Crovatto M, Ghionni A, Polato D, Lillini E, Pitzus E, Santini GF.

Am J Trop Med Hyg. 1993 Jan;48(1):20-5.

PMID:
8093990
46.

Phenotypic profile and functional characteristics of human gamma and delta T cells during acute toxoplasmosis.

De Paoli P, Basaglia G, Gennari D, Crovatto M, Modolo ML, Santini G.

J Clin Microbiol. 1992 Mar;30(3):729-31.

47.

Seroprevalence of antibodies to hantaviruses and leptospires in selected Italian population groups.

Nuti M, Amaddeo D, Autorino GL, Crovatto M, Crucil C, Ghionni A, Giommi M, Salvati F, Santini GF.

Eur J Epidemiol. 1992 Jan;8(1):98-102.

PMID:
1349288
48.

Borreliosis risk after tick bite in north-eastern Italy.

Milanese R, Marin M, Antonini-Canterin A, Crovatto M, Modolo ML, Scian I, Cilia AM, Santini GF.

Microbiologica. 1991 Jul;14(3):257-9.

PMID:
1921746
49.

A subset of gamma delta lymphocytes is increased during HIV-1 infection.

De Paoli P, Gennari D, Martelli P, Basaglia G, Crovatto M, Battistin S, Santini G.

Clin Exp Immunol. 1991 Feb;83(2):187-91.

50.

[Prevalence and determinants of HIV infection in 581 drug addicts in the Northeastern Italy, from 1984 to 1988].

Serraino D, Franceschi S, Vaccher E, Tirelli U, Crosatto I, Crovatto M, Moise M.

Epidemiol Prev. 1990 Dec;12(45):13-8. Italian.

PMID:
2151322

Supplemental Content

Loading ...
Support Center